Medicine pack check sheet

Source-linked reading points

• First check AVELOX, moxifloxacin, 400 mg, oral tablet and target market together. 400 mg is an identity field for that oral tablet, not an answer to how many tablets anyone should use today, for how long, or whether leftovers can be continued.
• The same FDA file also lists an intravenous product. Oral tablets and intravenous infusions differ in dosage form, route and handling requirements; intravenous-bag wording, oral-tablet numbers and another moxifloxacin or fluoroquinolone product must not be converted across one another.
• The FDA label includes warnings about serious fluoroquinolone reactions, heart-rhythm risk and interactions. With acute or serious symptoms such as tendon pain or swelling, numbness or tingling, marked neurologic or mental-status change, palpitations or fainting, breathing difficulty, rash, or swelling of the face or mouth, use timely local medical support rather than switching to another antibacterial medicine or continuing based on a webpage.
• Whether an antibacterial medicine is needed, which one is selected, route and course must be determined from the specific infection, testing, individual circumstances, complete medicine list and current target-market label. Especially with products that affect heart rhythm, glucose or anticoagulation, mineral-containing supplements, or multiple prescription/OTC products, bring the actual pack to a clinician or pharmacist for review.